Get Started

QURE

uniQure NV (QURE)

uniQure NV

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:QURE

<< Previous 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next >>

Date	Time	Source	Headline	Symbol	Company
04/10/2019	8:45AM	InvestorWire	Potential Blockbuster Gene Therapy Programs to Watch in 2019	NASDAQ:QURE	uniQure NV
04/09/2019	11:48AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:QURE	uniQure NV
04/08/2019	7:00AM	GlobeNewswire Inc.	uniQure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease	NASDAQ:QURE	uniQure NV
04/03/2019	4:34PM	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:QURE	uniQure NV
04/03/2019	12:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:QURE	uniQure NV
03/29/2019	7:00AM	GlobeNewswire Inc.	uniQure to Participate in Multiple Upcoming Industry Conferences	NASDAQ:QURE	uniQure NV
03/15/2019	3:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:QURE	uniQure NV
03/08/2019	1:14PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:QURE	uniQure NV
03/01/2019	7:00AM	GlobeNewswire Inc.	uniQure to Participate in Multiple Upcoming Industry Conferences	NASDAQ:QURE	uniQure NV
02/28/2019	3:36PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:QURE	uniQure NV
02/28/2019	8:31AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:QURE	uniQure NV
02/28/2019	7:00AM	GlobeNewswire Inc.	uniQure Announces 2018 Financial Results and Highlights Recent Company Progress	NASDAQ:QURE	uniQure NV
02/27/2019	4:03PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:QURE	uniQure NV
02/27/2019	7:00AM	GlobeNewswire Inc.	uniQure Presents New Preclinical Data on AMT-130 at the CHDI’s 14th Annual Huntington’s Disease Therapeutics Conference	NASDAQ:QURE	uniQure NV
02/21/2019	2:00PM	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:QURE	uniQure NV
02/20/2019	2:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:QURE	uniQure NV
02/15/2019	7:24AM	GlobeNewswire Inc.	uniQure Announces Publications on AAV Gene Therapy Approach to Treating Amyotrophic Lateral Sclerosis (ALS) and Frontotempora...	NASDAQ:QURE	uniQure NV
02/15/2019	7:24AM	GlobeNewswire Inc.	uniQure Announces Publications on AAV Gene Therapy Approach to Treating Amyotrophic Lateral Sclerosis (ALS) and Frontotempora...	NASDAQ:QURE	uniQure NV
02/14/2019	11:49AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:QURE	uniQure NV
02/14/2019	10:59AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:QURE	uniQure NV
02/14/2019	7:52AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:QURE	uniQure NV
02/13/2019	3:35PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:QURE	uniQure NV
02/13/2019	12:16PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:QURE	uniQure NV
02/08/2019	7:35AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:QURE	uniQure NV
02/08/2019	7:00AM	GlobeNewswire Inc.	uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B	NASDAQ:QURE	uniQure NV
02/04/2019	7:21AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:QURE	uniQure NV
02/04/2019	7:00AM	GlobeNewswire Inc.	uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of AMT-061 in Patients with Hemophilia B	NASDAQ:QURE	uniQure NV
01/31/2019	5:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:QURE	uniQure NV
01/31/2019	5:15PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:QURE	uniQure NV
01/30/2019	5:34PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:QURE	uniQure NV